Improving Access to Treatment of Gynecologic Cancers/Cervix Cancers

Photomedical approaches for the diagnosis and treatment of gynecologic cancers.

Malignant tumors of the female reproductive organs have a high incidence and mortality. Despite modern technology, diagnostics and therapeutics have substantial limitations. Detection of autofluorescence, photosensitizer mediated fluorescence, and near-infrared-spectra are new approaches to diagnose gynecologic malignancies and premalignant lesions. Photodynamic therapy (PDT) is currently being...

Laparoscopy for Gynecologic Cancers

Palliative Care in Gynecologic Cancers

Gynecologic cancers constitute a significant part of cancer load, especially in developing countries, and may be an important reason for mortality and morbidity for women in these countries. Procedures in diagnosis and treatment for gynecologic cancers might remain insufficient, and disorders related to symptoms may negatively influence the quality of life of women and their families. In this r...

Neoadjuvant Chemotherapy in Gynecologic Cancers

Neoadjuvant chemotherapy is introduced in many gynecologic cancers such as cervical and ovarian cancer. The aim of using neoadjuvant chemotherapy is to reduce the tumor size prior to the principle treatment, either radiation or surgery. The benefit of reducing tumor size can increase the operability and decrease the morbidity in many types of gynecologic cancers. Besides this, neoadjuvant chemo...

Novel approaches to improve the treatment of rare gynecologic cancers: research opportunities and challenges.

More than 50% of all gynecologic cancers can be classified as rare tumors (defined as an incidence of fewer than six per 100,000). Improved understanding of the molecular pathogenesis of tumors increases the proportion of rare tumors and creates challenges in optimizing the design of clinical trials. Novel trial designs are needed to take forward the development of new treatments in rare tumors...